12:00 AM
May 14, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Venilon: Phase II started

Teijin began Phase II testing of Venilon. Teijin is developing the compound with Kaketsuken. Teijin markets...

Read the full 57 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >